ArticleBMC ophthalmology2025
Outcomes of two-stage phacoemulsification and pars plana vitrectomy for proliferative diabetic retinopathy with coexisting cataract: a comparative study.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveThis study aims to compare the outcomes of a two-stage surgical approach in treating proliferative diabetic retinopathy (PDR) coexisting with cataract.
methodsThis retrospective study enrolled 97 eyes. Thirty eyes were assigned to sequential surgery: initial intravitreal pharmacotherapy administered concurrently with phacoemulsification and intraocular lens (IOL) implantation, followed by pars plana vitrectomy (PPV) one week postoperatively. The remaining 67 eyes underwent combined surgery, which entailed initial intravitreal pharmacotherapy followed one week later by simultaneous PPV, phacoemulsification and IOL implantation. The primary outcomes measured included early postoperative anterior chamber (AC) inflammation (degree of inflammatory cells and fibrinous exudate), posterior synechiae of the iris, best-corrected visual acuity (BCVA), intraocular pressure (IOP), and other intraoperative and postoperative complications.
resultsPost-vitrectomy day 1, in the sequential group, postoperative findings included AC cells ≥2+ in five eyes, fibrinous exudation in two eyes, and posterior synechiae of the iris in one eye. In the combined group, 28 eyes exhibited inflammatory cells≥2+ postoperatively, nine eyes presented with fibrinous exudation, and seven eyes developed posterior synechiae of the iris. The difference in the incidence of AC cell grade ≥2+ between the two groups was statistically significant (P < 0.05). Preoperative BCVA (LogMAR) in the sequential group was 1.88 ± 1.13, improving to 0.73 ± 0.77 at the final follow-up, showing statistically significant improvement (P < 0.05). In the combined group, preoperative BCVA (LogMAR) was 1.71 ± 1.08, improving to 0.74 ± 0.91 at the final follow-up, also showing significant improvement (P < 0.05). There was no statistically significant difference in postoperative BCVA (LogMAR) between the two groups (P>0.05). Binary logistic regression analysis identified sequential surgery as a significant protective factor against AC inflammation (OR 0.187, 95% CI 0.056-0.621, P = 0.006), indicating a substantially reduced risk of postoperative inflammatory reaction in the staged intervention cohort.
conclusionBoth sequential and combined surgical approaches are viable for the treatment of diabetic retinopathy with concomitant cataract. These findings indicate that sequential surgery helps reduce early postoperative inflammatory reactions; however, no significant difference in long-term efficacy has been observed between the two surgical methods. Clinical decision-making should be personalized, taking into account the patient's specific condition and the surgeon's expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.